<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d315">
    <sentence id="DDI-DrugBank.d315.s0" text="Digoxin: Coadministration of digoxin, a P-glycoprotein substrate, with oral conivaptan resulted in a reduction in clearance and an increase in digoxin Cmax and AUC values.">
        <entity id="DDI-DrugBank.d315.s0.e0" charOffset="0-6"
            type="drug" text="Digoxin"/>
        <entity id="DDI-DrugBank.d315.s0.e1" charOffset="29-35"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d315.s0.e2" charOffset="76-85"
            type="drug" text="conivaptan"/>
        <entity id="DDI-DrugBank.d315.s0.e3" charOffset="143-149"
            type="drug" text="digoxin"/>
        <ddi id="DDI-DrugBank.d315.s0.d0" e1="DDI-DrugBank.d315.s0.e1"
            e2="DDI-DrugBank.d315.s0.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d315.s1" text="Therefore, if digoxin is administered with VAPRISOL, the clinician should be alert to the possibility of increases in digoxin levels.">
        <entity id="DDI-DrugBank.d315.s1.e0" charOffset="14-20"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d315.s1.e1" charOffset="43-50"
            type="brand" text="VAPRISOL"/>
        <entity id="DDI-DrugBank.d315.s1.e2" charOffset="118-124"
            type="drug" text="digoxin"/>
        <ddi id="DDI-DrugBank.d315.s1.d0" e1="DDI-DrugBank.d315.s1.e0"
            e2="DDI-DrugBank.d315.s1.e1" type="mechanism"/>
    </sentence>
</document>
